MedPath

Optimal reversal dose of Sugammadex in a short post-operative period in adult patients

Not Applicable
Completed
Conditions
the patients scheduled for elective surgery requiring general anesthesia
Registration Number
JPRN-UMIN000007245
Lead Sponsor
Department of Anesthesiology and Critical Care Medicine, Asahikawa Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

the patients were ASA physical status 3-4. the diabetic patients. the patients who heve neurodegenerating disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.